Abstract:Although heart failure due to a wide variety of pathological stimuli including myocardial infarction, pressure overload and volume overload is associated with cardiac hypertrophy, the exact reasons for the transition of cardiac hypertrophy to heart failure are not well defined. Since circulating levels of several vasoactive hormones including catecholamines, angiotensin II, and endothelins are elevated under pathological conditions, it has been suggested that these vasoactive hormones may be involved in the development of both cardiac hypertrophy and heart failure. At initial stages of pathological stimuli, these hormones induce an increase in ventricular wall tension by acting through their respective receptor-mediated signal transduction systems and result in the development of cardiac hypertrophy. Some oxyradicals formed at initial stages are also involved in the redox-dependent activation of the hypertrophic process but these are rapidly removed by increased content of antioxidants in hypertrophied heart. In fact, cardiac hypertrophy is considered to be an adaptive process as it exhibits either normal or augmented cardiac function for maintaining cardiovascular homeostasis. However, exposure of a hypertrophied heart to elevated levels of circulating hormones due to pathological stimuli over a prolonged period results in cardiac dysfunction and development of heart failure involving a complex set of mechanisms. It has been demonstrated that different cardiovascular abnormalities such as functional hypoxia, metabolic derangements, uncoupling of mitochondrial electron transport, and inflammation produce oxidative stress in the hypertrophied failing hearts. In addition, oxidation of catecholamines by monoamine oxidase as well as NADPH oxidase activation by angiotensin II and endothelin promote the generation of oxidative stress during the prolonged period by these pathological stimuli. It is noteworthy that oxidative stress is known to activate metallomatrix proteases and degrade the extracellular matrix proteins for the induction of cardiac remodeling and heart dysfunction. Furthermore, oxidative stress has been shown to induce subcellular remodeling and Ca2+-handling abnormalities as well as loss of cardiomyocytes due to the development of apoptosis, necrosis, and fibrosis. These observations support the view that a low amount of oxyradical formation for a brief period may activate redox-sensitive mechanisms, which are associated with the development of cardiac hypertrophy. On the other hand, high levels of oxyradicals over a prolonged period may induce oxidative stress and cause Ca2+-handling defects as well as protease activation and thus play a critical role in the development of adverse cardiac remodeling and cardiac dysfunction as well as progression of heart failure.

Status of Mitochondrial Oxidative Phosphorylation during the Development of Heart Failure

Posttranslational modifications and dysfunction of mitochondrial enzymes in human heart failure

Mitochondria-associated membrane-modulated Ca<SUP>2+</SUP> transfer: A potential treatment target in cardiac ischemia reperfusion injury and heart failure

Mitochondrial Calcium Overload Plays a Causal Role in Oxidative Stress in the Failing Heart

Mitochondrial ATPase and High-Energy Phosphates in Failing Hearts.

Advances in myocardial energy metabolism: metabolic remodeling in heart failure and beyond

Mitochondrial Dysfunction in Heart Failure and Its Therapeutic Implications

A Mitochondrial Basis for Heart Failure Progression

Mitochondrial Dysfunction and Calcium Homeostasis in Heart Failure: Exploring the Interplay Between Oxidative Stress and Cardiac Remodeling for Future Therapeutic Innovations

Alterations in Mitochondrial Oxidative Phosphorylation System: Relationship of Complex V and Cardiac Dysfunction in Human Heart Failure

Cardiac Energy Metabolism in Heart Failure

Mitochondrial dysfunction and mitochondrial therapies in heart failure

Mitochondrial Dysfunction in Cardiac Disease: The Fort Fell

Mitochondrial Ca2+ in Heart Failure: Not Enough or Too Much?

From Pathophysiological Mechanisms to Therapeutic Opportunities

Abstract 16529: Coupling of Mitochondrial Respiration and Superoxide Production in Healthy and Failing Hearts

Mitochondrial Oxidative Phosphorylation defect in the Heart of Subjects with Coronary Artery Disease

Mitochondrial calcium regulation of cardiac metabolism in health and disease

Mitochondrial fatty acid oxidation is the major source of cardiac ATP production in heart failure with preserved ejection fraction

Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure

Proteomic Analysis of Mitochondria Reveals a Metabolic Switch from Fatty Acid Oxidation to Glycolysis in the Failing Heart.